Contact us

Have questions? Want to talk about your next project? Our experts are here to help. Please complete the form below and we will be happy to respond to you.


1675 Rte Transcanadienne, #135
Dorval, QC – Canada H9P 1J1

Phone+1 (514) 339-5986
Fax+1 (514 ) 375-1360

The Future Is Now

Capcium has developed a two-phase commercial strategy to best serve our customer.

Our Facility

On-Site Nutraceutical Production

Capcium received its site license from Health Canada to manufacture softgel capsules for the nutraceutical industry in 2015. Since then, we have been producing sofgels for our customers in our cGMP compliant St. Laurent, Quebec facility.

Co-Location of Encapsulation Equipment for CBD Product Production

Until our new, state-of-the-art Pointe-Claire facility is fully operational, Capcium will produce softgel capsules for Licensed Producers at a premises licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). To date, Capcium has one fully operational encapsulation line at Aurora’s Montreal-based facility (“Aurora Vie”) and is in the process of completing the installation of additional encapsulation lines at other sites licensed under the ACMPR to service further CBD customers’ needs.

Phase 2
Capcium Tandem Facility

All Production Under One Roof

Phase II of Capcium’s commercial plan will be to produce all pharmaceutical, nutraceutical and CBD products at our new facility in Pointe-Claire, Quebec. Construction of the New Facility is well advanced and is expected to be completed in mid 2020.

The New Facility will be pharmaceutical grade and compliant with all major cGMP pharmaceutical standards, including Health Canada, FDA and EMEA.  As a result, Capcium will be able to service the highest-grade pharmaceutical production.

The New Facility will be the first of its kind, state-of-the-art facility, designed specifically for the development and manufacture of pharmaceutical, nutraceutical and CBD products.